Bioneer KRX:064550KOSDAQ
바이오니아 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked5since Sep 11
In Q2 2026, Bioneer reported revenue of ₩96.2bn, up 8.9% year on year, and operating profit of ₩1.2bn. Bioneer (바이오니아) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals Insider buying Screener
Bioneer quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩96.2bn | +8.9% | ₩1.2bn margin 1.2% | −₩1.1bn |
| Q1 2026 | ₩81.8bn | +10.7% | −₩526m margin −0.6% | −₩2.8bn |
| Q4 2025 derived | ₩79.9bn | +13.4% | ₩2.7bn margin 3.4% | ₩166m |
| Q3 2025 | ₩88.1bn | +33.7% | ₩2.9bn margin 3.3% | ₩63m |
| Q2 2025 | ₩88.3bn | +12.5% | ₩5.3bn margin 6.0% | ₩345m |
| Q1 2025 | ₩73.9bn | -6.7% | ₩4.3bn margin 5.9% | ₩1.1bn |
| Q4 2024 derived | ₩70.4bn | +9.9% | −₩7.4bn margin −10.5% | −₩8.2bn |
| Q3 2024 | ₩65.9bn | -10.7% | −₩8.2bn margin −12.4% | −₩9.6bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Bioneer top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.